ECU Libraries Catalog

CNS clinical trials : suicidality and data collection : workshop summary / Sarah Hanson, Miriam Davis, and Bruce Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Format Electronic and Book
Publication InfoWashington, D.C. : National Academies Press,
Descriptionxii, 75 p. : ill. ; 23 cm.
Supplemental Content Full text available from Ebook Central - Academic Complete
Subject(s)
Other author/creatorHanson, Sarah L. (Sarah Lynn), 1980-
Other author/creatorDavis, Miriam (Medical writer)
Other author/creatorAltevogt, Bruce M.
Other author/creatorInstitute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders.
Other author/creatorNational Academies Press (U.S.)
Variant title Central nervous system clinical trials
Contents Perspectives from the FDA, academia, and patients -- Data collection and optimization -- Data analysis -- Partnerships, opportunities, collaboration.
Abstract "The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description.
Bibliography noteIncludes bibliographical references (p. 43-49).
Access restrictionAvailable only to authorized users.
Other formsAlso issued online.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2012419234
ISBN9780309148832 (pbk.)
ISBN0309148839 (pbk.)

Available Items

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available